Navigation Links
Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
Date:9/11/2008

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 36 countries and has 8,000 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit our award-winning website at http://www.sigma-aldrich.com.

About IsoSciences: IsoSciences, LLC is a leader in providing custom synthesized isotopically labeled compounds including intermediates, final drug substances, and isotopically labeled biological standards. IsoSciences works with the world's leading pharmaceutical companies, diagnostic laboratories, medical researchers and other companies requiring stable-isotope labeled compounds for R&D. For more information about products and services offered by IsoSciences, LLC please visit http://www.isosciences.com.

Cautionary Statement: This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Companies' expectations, goals, beliefs, intentions and the like, which involve assumptions regarding the Companies' operations and conditions in the markets the Companies serve. The Companies do not undertake any obligation to update these forward-looking statements.

Sigma-Ald
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
2. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
3. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
4. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
5. Sigma-Aldrich to Present at the UBS 2007 Global Life Sciences Conference on September 25, 2007
6. Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
7. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
8. Sigma-Aldrich Corporations 3rd Quarter 2007 Earnings Conference Call
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
11. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...cently announced that Dr. Dominique Hebrault will ... Analytical Technology (PAT) in Green Chemistry an... (PRWEB) November 20, 2009...hnology (PAT) in Green Chemistry and Green Enginee...chnology (PAT) case studies will be presented on h...
(Date:11/19/2009)...ire/ -- Dr. Mate Hidvegi, inventor of Avemar ferme...se issued on November 17 by Biropharma Kft, discre...self-serving statements about its U.S. competitor ...om his office in Budapest, Hungary: ,, "The Bi...ply to AveULTRA, www.aveultra.com , is misleadi...
(Date:11/19/2009)...ss., Nov. 19 Arlington Medical Res...leading driver of antibiotic selection in nosocomi...against gram-positive and gram-negative pathogens....socomial pneumonia, surveyed European physicians r...vide appropriate coverage against common pathogens...
(Date:11/19/2009)...Synthesis Companies Form International Gene Synthe... in Risk Reduction ,Five Member Companies Repres...y , (PRWEB) November 19, ...thesis companies today announced agreement that th...te biosecurity in the gene synthesis industry. By...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...um to be held April 17, 2008, GRAND RAPIDS, Mich....Initiative (WMSTI) is accepting exhibitor applicat...nual Life Science Business,Showcase, Night at the ..., Night at the Museum is seeking regional exhibit... from up-and-coming startups in pharma research to...
... Feb. 19 National Stem,Cell Holding, Inc. (OTC: N... Arnold Securities, Inc. ("BMA Securities") to pro... respect to assisting and advising the,company wit...urities is a FINRA member full service brokerage f...al services, which include: market,making, institu...
...February 19 ChemAxon, a software,solutions provid...of,version 5 of their cheminformatics toolkits, Ma...n Marvin user friendliness, Markush enumeration an... Oracle Cartridge,performance., Marvin & JChem is...I,s),and graphic user interfaces (GUI,s) used by l...
Other Biology Technology:West Michigan Science & Technology Initiative Seeks Exhibitors for Annual Life Science Showcase 2National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of $3,500,000 2ChemAxon Launches Marvin and JChem Version 5: Better User Experience, Better Integration, More Flexibility and Higher Performance 2
(Date:11/21/2009)...y, November 20,2009 / b3c newswire / - KINAXO Bi...financing round, gaining two new investors in the ...me KINAXO reports that Jrgen Schumacher has been e...ard. , KINAXO shareholders Axel Ullrich, Hellmut...institutional investors Mountain Partners, BioM, H...
(Date:11/20/2009)...ort published in the November 2009 issue of the jo...ntists show how a family of genes (1-aminocyclopro...ponsible for production of ethylene. This gas affe...formation lays the foundation for future genetic m...nt, able to survive and thrive in difficult terrai...
(Date:11/20/2009)...ise measurements of plasma lipoprotein concentrati...roscopy (NMR), researchers led by Daniel Chasman a... School in Boston, MA, the Framingham Heart Study ...ckholm, Sweden and Oxford, England performed genet...ong 17,296 women of European ancestry from the Wom...
Breaking Biology News(10 mins):KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3It's a gas: New discovery may lead to heartier, high-yielding plants 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility 14603 1Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility 14603 2Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility 14603 3NxStage 28R 29 Reports Significant Interim FREEDOM Study Results 5732 1NxStage 28R 29 Reports Significant Interim FREEDOM Study Results 5732 2NxStage 28R 29 Reports Significant Interim FREEDOM Study Results 5732 3Logical Therapeutics Announces Positive Results of LT NS001 vs Naproxen Clinical Study 5727 1Logical Therapeutics Announces Positive Results of LT NS001 vs Naproxen Clinical Study 5727 2Logical Therapeutics Announces Positive Results of LT NS001 vs Naproxen Clinical Study 5727 3Logical Therapeutics Announces Positive Results of LT NS001 vs Naproxen Clinical Study 5727 4
...ken a "snapshot" of a Velcro-like protein on a cel...irus, a linkup thought to initiate the early stage...squitoes, infects more than 50 million people annu... tropical regions. , During the earliest stages o...bohydrate recognition domain," or CRD, of a key bi...
... molecule which they believe could ultimately lead... genetically modified tobacco. Writing in Plant Bi...agues from St George,s, University of London along... they have overcome a major barrier that has so fa...ally viable "bioreactors" for vaccines. , By creat...
...ls and immune cells called macrophages may be a so...the effectiveness of androgen antagonists, the mos...er, according to a new study by researchers at the... of Medicine. , Male hormones called androgens a...owth of the prostate gland, and anti-androgen trea...
Other Biology News:Biologists visualize protein interaction that may initiate viral infection 2Biologists visualize protein interaction that may initiate viral infection 3Do plants have the potential to vaccinate against HIV? 2Macrophage signaling may affect hormone resistance in prostate tumors 2
...an B4i ventilated and BR4i refrigerated multifunct...and low speed operation at a low sound level with ...for biocontainment. Their AUTO-LOCK rotor exchange...tor is ready for use within seconds. Instant rot...
...bank refrigerators: ,Each upright model provides ...erior 4C temperature uniformity for refrigerated b... Surveillance Module for complete blood storage mo... equipped with the HemaPro 101 alarm/monitor. All ...
Electroporation Cuvettes, 4 mm gap. 50 from Thermo Scientific
...rotease is an enhanced form of Tobacco Etch Virus ...y active, and significantly more stable than nativ...cTEV Protease specifically recognizes a seven amin...een Gln and Gly), making it useful for removing af...
Biology Products: